After LabCorp (LH) reported a mixed Q1, with better than expected earnings and lower than expected revenue, Piper Jaffray analyst William Quirk said he found it interesting that management noted volumes from UnitedHealth (UNH) and CVS Health’s (CVS) Aetna is stable after the initial decline in January. He thinks this implies that LabCorp and Quest (DGX) are likely taking some incremental volume from regional payers, adding that this is sooner than he anticipated following the new managed care deals. However, management “remains coy” about the future impact from other volume consolidating programs, such as UnitedHealth’s Preferred Lab Network, according to Quirk. He keeps an Overweight rating on LabCorp shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.